Ottimo Pharma
Ottimo Pharma is a private biotech company developing bifunctional medicines for cancer treatment. Their lead asset, Jankistomig, is a first-in-class PD1/VEGFR2 bifunctional antibody targeting immune checkpoint inhibition and angiogenesis. This innovative approach aims to improve outcomes across multiple solid tumor indications.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $140M
Date: 19-Dec-2024
Investors: OrbiMed, Avoro Capital, Samsara BioCapital, RTW Investments, Decheng Capital, Janus Henderson Investors, J.P. Morgan Life Sciences Private Capital, Invus, Medicxi
Markets: Biotechnology, Oncology, Health Care, Pharmaceutical
HQ: Sandwich, Kent, United Kingdom
Founded: 2017
Website: https://ottimopharma.com/
LinkedIn: https://www.linkedin.com/company/ottimo-pharma
Crunchbase: https://www.crunchbase.com/organization/ottimo-pharma
Leave a Comment
Comments
No comments yet.